NEWS COMMENTARY

Brightseed forms alliance with Pharmavite for phytonutrient discovery

Published:
November 25, 2020
Services:
Consumer
Activities:
Partnership
by Thomas Hayes
Average importance

This adds to Brightseed's growing momentum, having also announced a partnership with Danone and closing a $27 million funding round in the past six months. In an interview with both companies, Pharmavite revealed that identifying ingredients for sleep will be an initial focus area. When and how Pharmavite plans to commercialize discoveries from Brightseed's platform is unclear at this time, however. Using Nuritas, which Pharmavite has also partnered with, as a competitive benchmark to Brightseed, this could take somewhere around two years. As functional ingredients become increasingly important in light of COVID-19, we encourage clients to pursue novel ways to identify next-generation ingredients that provide health benefits.

For the original news article, click here .


Further Reading

Growing momentum for mycoproteins in Europe as Enough and Mycorena raise funding

News Commentary | June 24, 2021

Just this week, two European mycoproteins startups raised funding: Enough raised $51 million in a Series B round led by Nutreco, and Mycorena raised a $9 million pre‑Series A round led by Belgian ingredient company Veos. This cash injection will help both companies to develop their respective ... Not part of subscription

Perfect Day raises $350 million Series D and expands its product portfolio

News Commentary | October 04, 2021

Led by Temasek Holdings, this Series D funding round brings Perfect Day's total funding to about $750 million. The company also announced the launch of an alternative cheese brand, "Modern Kitchen," made with fermentation‑derived dairy proteins. This move will now place Perfect Day alongside ... Not part of subscription

Will Ginkgo-backed Arcaea "regenerate" the beauty industry with its $78 million Series A?

News Commentary | October 28, 2021

Arcaea is looking to answer what is possible for beauty by leveraging biotech to grow novel ingredients and create supply chains that don't rely on petrochemicals or scarce resources. So far, the company seems to have the means and partnerships to achieve its goals. It has a strong lineup of ... Not part of subscription